## Abstract The clinical response of a 53‐year‐old woman with tardive dyskinesia treated with bilateral globus pallidus interna deep brain stimulation is described. At 18 months follow‐up, her Burke–Fahn–Marsden Dystonia Rating Scale score fell from 52 (preoperative) to 21 (60% improvement). © 2004
Unilateral deep brain stimulation of the internal globus pallidus alleviates tardive dyskinesia
✍ Scribed by Christoph Schrader; Thomas Peschel; Michael Petermeyer; Reinhard Dengler; Dieter Hellwig
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 514 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We describe a patient with fluspirilene‐induced tardive dyskinesia of the choreiform oro‐facial‐laryngeal type resistant to various conservative approaches for 7 years who underwent deep brain stimulation of the internal pallidal globe. We found immediate and marked suppression of her perioral involuntary movements with unilateral stimulation at 60 Hz. © 2003 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract Tardive dystonia is a disabling movement disorder as a consequence of exposure to neuroleptic drugs. We followed 6 patients with medically refractory tardive dystonia treated by bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) for 21 ± 18 months. At last follow‐up,
## Abstract Stimulation (DBS) of the globus pallidus (GP) is effective to treat generalized dystonia. Little is known about the evolution of dystonia in case of arrest after a long period of stimulation. This study describes the course of dystonia during a 48 hours period without stimulation follow
## Abstract Deep brain stimulation (DBS) of the globus pallidus internus (GPi) is an effective treatment in primary dystonia. Its success depends on the implantation accuracy of the DBS electrode into the targeted GPi. Discrepancies of up to 4 mm between the initial target, selected on preoperative
We report the therapeutic effects of deep brain stimulation (DBS) in 2 patients with Parkinson's disease (PD) with severe end of dose dyskinesia that was resistant to medical therapy. In both patients, severe, end of day ballistic dyskinesias occurred when the last levodopa dose of the day was weari
Deep brain stimulation remains an experimental treatment for patients with Gilles de la Tourette syndrome. Currently, a major controversial issue is the choice of brain target that leads to optimal patient outcomes within a presumed network of basal ganglia and cortical pathways involved in tic path